HEADER TRANSFERASE 27-OCT-05 2D51 TITLE PENTAKETIDE CHROMONE SYNTHASE (M207G MUTANT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENTAKETIDE CHROMONE SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ALOE ARBORESCENS; SOURCE 3 ORGANISM_TAXID: 45385; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET24A KEYWDS PENTAKETIDE CHROMONE SYNTHASE, CHALCONE SYNTHASE, POLYKETIDE KEYWDS 2 SYNTHASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KOHNO,H.MORITA REVDAT 4 10-NOV-21 2D51 1 SEQADV LINK REVDAT 3 24-FEB-09 2D51 1 VERSN REVDAT 2 15-MAY-07 2D51 1 JRNL REMARK REVDAT 1 14-NOV-06 2D51 0 JRNL AUTH H.MORITA,S.KONDO,S.OGURO,H.NOGUCHI,S.SUGIO,I.ABE,T.KOHNO JRNL TITL STRUCTURAL INSIGHT INTO CHAIN-LENGTH CONTROL AND PRODUCT JRNL TITL 2 SPECIFICITY OF PENTAKETIDE CHROMONE SYNTHASE FROM ALOE JRNL TITL 3 ARBORESCENS JRNL REF CHEM.BIOL. V. 14 359 2007 JRNL REFN ISSN 1074-5521 JRNL PMID 17462571 JRNL DOI 10.1016/J.CHEMBIOL.2007.02.003 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 117664 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 5939 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6193 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 592 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2D51 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000024995. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JAN-05 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 117664 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.52500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 406 REMARK 465 GLY B 1 REMARK 465 PRO B 2 REMARK 465 GLY B 3 REMARK 465 MET B 4 REMARK 465 SER B 5 REMARK 465 SER B 6 REMARK 465 LEU B 7 REMARK 465 SER B 8 REMARK 465 ASN B 9 REMARK 465 SER B 10 REMARK 465 MET B 406 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 15 50.33 -69.94 REMARK 500 SER A 103 -2.89 -145.09 REMARK 500 ASP A 240 70.58 53.05 REMARK 500 MET A 353 30.27 -95.66 REMARK 500 VAL A 354 -128.19 54.44 REMARK 500 TYR B 99 -65.01 -91.72 REMARK 500 SER B 103 -3.01 -141.17 REMARK 500 HIS B 218 71.17 -118.65 REMARK 500 VAL B 354 -129.20 53.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 170 0.07 SIDE CHAIN REMARK 500 TYR B 170 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2D3M RELATED DB: PDB REMARK 900 PENTAKETIDE CHROMONE SYNTHASE COMPLEXED WITH COENZYME A REMARK 900 RELATED ID: 1BQ6 RELATED DB: PDB REMARK 900 CHALCONE SYNTHASE FROM ALFALFA WITH COENZYME A REMARK 900 RELATED ID: 1EE0 RELATED DB: PDB REMARK 900 2-PYRONE SYNTHASE COMPLEXED WITH ACETOACETYL-COA REMARK 900 RELATED ID: 2D52 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXD WITH COA DBREF 2D51 A 4 406 UNP Q58VP7 Q58VP7_ALOAR 1 403 DBREF 2D51 B 4 406 UNP Q58VP7 Q58VP7_ALOAR 1 403 SEQADV 2D51 GLY A 1 UNP Q58VP7 CLONING ARTIFACT SEQADV 2D51 PRO A 2 UNP Q58VP7 CLONING ARTIFACT SEQADV 2D51 GLY A 3 UNP Q58VP7 CLONING ARTIFACT SEQADV 2D51 CSD A 177 UNP Q58VP7 CYS 174 MODIFIED RESIDUE SEQADV 2D51 GLY A 210 UNP Q58VP7 MET 207 ENGINEERED MUTATION SEQADV 2D51 GLY B 1 UNP Q58VP7 CLONING ARTIFACT SEQADV 2D51 PRO B 2 UNP Q58VP7 CLONING ARTIFACT SEQADV 2D51 GLY B 3 UNP Q58VP7 CLONING ARTIFACT SEQADV 2D51 CSD B 177 UNP Q58VP7 CYS 174 MODIFIED RESIDUE SEQADV 2D51 GLY B 210 UNP Q58VP7 MET 207 ENGINEERED MUTATION SEQRES 1 A 406 GLY PRO GLY MET SER SER LEU SER ASN SER LEU PRO LEU SEQRES 2 A 406 MET GLU ASP VAL GLN GLY ILE ARG LYS ALA GLN LYS ALA SEQRES 3 A 406 ASP GLY THR ALA THR VAL MET ALA ILE GLY THR ALA HIS SEQRES 4 A 406 PRO PRO HIS ILE PHE PRO GLN ASP THR TYR ALA ASP VAL SEQRES 5 A 406 TYR PHE ARG ALA THR ASN SER GLU HIS LYS VAL GLU LEU SEQRES 6 A 406 LYS LYS LYS PHE ASP HIS ILE CYS LYS LYS THR MET ILE SEQRES 7 A 406 GLY LYS ARG TYR PHE ASN TYR ASP GLU GLU PHE LEU LYS SEQRES 8 A 406 LYS TYR PRO ASN ILE THR SER TYR ASP GLU PRO SER LEU SEQRES 9 A 406 ASN ASP ARG GLN ASP ILE CYS VAL PRO GLY VAL PRO ALA SEQRES 10 A 406 LEU GLY THR GLU ALA ALA VAL LYS ALA ILE GLU GLU TRP SEQRES 11 A 406 GLY ARG PRO LYS SER GLU ILE THR HIS LEU VAL PHE CYS SEQRES 12 A 406 THR SER CYS GLY VAL ASP MET PRO SER ALA ASP PHE GLN SEQRES 13 A 406 CYS ALA LYS LEU LEU GLY LEU HIS ALA ASN VAL ASN LYS SEQRES 14 A 406 TYR CYS ILE TYR MET GLN GLY CSD TYR ALA GLY GLY THR SEQRES 15 A 406 VAL MET ARG TYR ALA LYS ASP LEU ALA GLU ASN ASN ARG SEQRES 16 A 406 GLY ALA ARG VAL LEU VAL VAL CYS ALA GLU LEU THR ILE SEQRES 17 A 406 MET GLY LEU ARG ALA PRO ASN GLU THR HIS LEU ASP ASN SEQRES 18 A 406 ALA ILE GLY ILE SER LEU PHE GLY ASP GLY ALA ALA ALA SEQRES 19 A 406 LEU ILE ILE GLY SER ASP PRO ILE ILE GLY VAL GLU LYS SEQRES 20 A 406 PRO MET PHE GLU ILE VAL CYS THR LYS GLN THR VAL ILE SEQRES 21 A 406 PRO ASN THR GLU ASP VAL ILE HIS LEU HIS LEU ARG GLU SEQRES 22 A 406 THR GLY MET MET PHE TYR LEU SER LYS GLY SER PRO MET SEQRES 23 A 406 THR ILE SER ASN ASN VAL GLU ALA CYS LEU ILE ASP VAL SEQRES 24 A 406 PHE LYS SER VAL GLY ILE THR PRO PRO GLU ASP TRP ASN SEQRES 25 A 406 SER LEU PHE TRP ILE PRO HIS PRO GLY GLY ARG ALA ILE SEQRES 26 A 406 LEU ASP GLN VAL GLU ALA LYS LEU LYS LEU ARG PRO GLU SEQRES 27 A 406 LYS PHE ARG ALA ALA ARG THR VAL LEU TRP ASP TYR GLY SEQRES 28 A 406 ASN MET VAL SER ALA SER VAL GLY TYR ILE LEU ASP GLU SEQRES 29 A 406 MET ARG ARG LYS SER ALA ALA LYS GLY LEU GLU THR TYR SEQRES 30 A 406 GLY GLU GLY LEU GLU TRP GLY VAL LEU LEU GLY PHE GLY SEQRES 31 A 406 PRO GLY ILE THR VAL GLU THR ILE LEU LEU HIS SER LEU SEQRES 32 A 406 PRO LEU MET SEQRES 1 B 406 GLY PRO GLY MET SER SER LEU SER ASN SER LEU PRO LEU SEQRES 2 B 406 MET GLU ASP VAL GLN GLY ILE ARG LYS ALA GLN LYS ALA SEQRES 3 B 406 ASP GLY THR ALA THR VAL MET ALA ILE GLY THR ALA HIS SEQRES 4 B 406 PRO PRO HIS ILE PHE PRO GLN ASP THR TYR ALA ASP VAL SEQRES 5 B 406 TYR PHE ARG ALA THR ASN SER GLU HIS LYS VAL GLU LEU SEQRES 6 B 406 LYS LYS LYS PHE ASP HIS ILE CYS LYS LYS THR MET ILE SEQRES 7 B 406 GLY LYS ARG TYR PHE ASN TYR ASP GLU GLU PHE LEU LYS SEQRES 8 B 406 LYS TYR PRO ASN ILE THR SER TYR ASP GLU PRO SER LEU SEQRES 9 B 406 ASN ASP ARG GLN ASP ILE CYS VAL PRO GLY VAL PRO ALA SEQRES 10 B 406 LEU GLY THR GLU ALA ALA VAL LYS ALA ILE GLU GLU TRP SEQRES 11 B 406 GLY ARG PRO LYS SER GLU ILE THR HIS LEU VAL PHE CYS SEQRES 12 B 406 THR SER CYS GLY VAL ASP MET PRO SER ALA ASP PHE GLN SEQRES 13 B 406 CYS ALA LYS LEU LEU GLY LEU HIS ALA ASN VAL ASN LYS SEQRES 14 B 406 TYR CYS ILE TYR MET GLN GLY CSD TYR ALA GLY GLY THR SEQRES 15 B 406 VAL MET ARG TYR ALA LYS ASP LEU ALA GLU ASN ASN ARG SEQRES 16 B 406 GLY ALA ARG VAL LEU VAL VAL CYS ALA GLU LEU THR ILE SEQRES 17 B 406 MET GLY LEU ARG ALA PRO ASN GLU THR HIS LEU ASP ASN SEQRES 18 B 406 ALA ILE GLY ILE SER LEU PHE GLY ASP GLY ALA ALA ALA SEQRES 19 B 406 LEU ILE ILE GLY SER ASP PRO ILE ILE GLY VAL GLU LYS SEQRES 20 B 406 PRO MET PHE GLU ILE VAL CYS THR LYS GLN THR VAL ILE SEQRES 21 B 406 PRO ASN THR GLU ASP VAL ILE HIS LEU HIS LEU ARG GLU SEQRES 22 B 406 THR GLY MET MET PHE TYR LEU SER LYS GLY SER PRO MET SEQRES 23 B 406 THR ILE SER ASN ASN VAL GLU ALA CYS LEU ILE ASP VAL SEQRES 24 B 406 PHE LYS SER VAL GLY ILE THR PRO PRO GLU ASP TRP ASN SEQRES 25 B 406 SER LEU PHE TRP ILE PRO HIS PRO GLY GLY ARG ALA ILE SEQRES 26 B 406 LEU ASP GLN VAL GLU ALA LYS LEU LYS LEU ARG PRO GLU SEQRES 27 B 406 LYS PHE ARG ALA ALA ARG THR VAL LEU TRP ASP TYR GLY SEQRES 28 B 406 ASN MET VAL SER ALA SER VAL GLY TYR ILE LEU ASP GLU SEQRES 29 B 406 MET ARG ARG LYS SER ALA ALA LYS GLY LEU GLU THR TYR SEQRES 30 B 406 GLY GLU GLY LEU GLU TRP GLY VAL LEU LEU GLY PHE GLY SEQRES 31 B 406 PRO GLY ILE THR VAL GLU THR ILE LEU LEU HIS SER LEU SEQRES 32 B 406 PRO LEU MET MODRES 2D51 CSD A 177 CYS 3-SULFINOALANINE MODRES 2D51 CSD B 177 CYS 3-SULFINOALANINE HET CSD A 177 8 HET CSD B 177 8 HETNAM CSD 3-SULFINOALANINE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD 2(C3 H7 N O4 S) FORMUL 3 HOH *592(H2 O) HELIX 1 1 SER A 6 SER A 10 5 5 HELIX 2 2 ASP A 16 LYS A 25 1 10 HELIX 3 3 THR A 48 THR A 57 1 10 HELIX 4 4 LYS A 62 LYS A 75 1 14 HELIX 5 5 ASP A 86 LYS A 91 1 6 HELIX 6 6 SER A 103 GLY A 131 1 29 HELIX 7 7 PRO A 133 ILE A 137 5 5 HELIX 8 8 SER A 152 GLY A 162 1 11 HELIX 9 9 GLN A 175 CSD A 177 5 3 HELIX 10 10 TYR A 178 ASN A 193 1 16 HELIX 11 11 LEU A 206 GLY A 210 5 5 HELIX 12 12 ASP A 220 PHE A 228 1 9 HELIX 13 13 GLY A 283 SER A 302 1 20 HELIX 14 14 ASP A 310 LEU A 314 5 5 HELIX 15 15 GLY A 322 LEU A 333 1 12 HELIX 16 16 PHE A 340 GLY A 351 1 12 HELIX 17 17 MET A 353 SER A 355 5 3 HELIX 18 18 ALA A 356 LYS A 372 1 17 HELIX 19 19 LEU B 13 GLU B 15 5 3 HELIX 20 20 ASP B 16 LYS B 25 1 10 HELIX 21 21 THR B 48 THR B 57 1 10 HELIX 22 22 LYS B 62 LYS B 75 1 14 HELIX 23 23 ASP B 86 LYS B 91 1 6 HELIX 24 24 SER B 103 GLY B 131 1 29 HELIX 25 25 PRO B 133 ILE B 137 5 5 HELIX 26 26 SER B 152 GLY B 162 1 11 HELIX 27 27 GLN B 175 CSD B 177 5 3 HELIX 28 28 TYR B 178 ASN B 193 1 16 HELIX 29 29 LEU B 206 GLY B 210 5 5 HELIX 30 30 ASP B 220 PHE B 228 1 9 HELIX 31 31 GLY B 283 SER B 302 1 20 HELIX 32 32 ASP B 310 LEU B 314 5 5 HELIX 33 33 GLY B 322 LEU B 333 1 12 HELIX 34 34 ARG B 336 LYS B 339 5 4 HELIX 35 35 PHE B 340 GLY B 351 1 12 HELIX 36 36 MET B 353 SER B 355 5 3 HELIX 37 37 ALA B 356 LYS B 372 1 17 SHEET 1 A 9 ASN A 168 TYR A 173 0 SHEET 2 A 9 HIS A 139 THR A 144 1 N PHE A 142 O ILE A 172 SHEET 3 A 9 ARG A 198 GLU A 205 1 O VAL A 202 N VAL A 141 SHEET 4 A 9 GLY A 231 GLY A 238 -1 O ILE A 237 N VAL A 199 SHEET 5 A 9 THR A 31 ALA A 38 -1 N GLY A 36 O ALA A 234 SHEET 6 A 9 PHE A 250 VAL A 259 -1 O PHE A 250 N VAL A 32 SHEET 7 A 9 THR A 394 SER A 402 -1 O HIS A 401 N GLU A 251 SHEET 8 A 9 TRP A 383 GLY A 390 -1 N GLY A 384 O LEU A 400 SHEET 9 A 9 PHE A 315 PRO A 318 1 N ILE A 317 O VAL A 385 SHEET 1 B 2 HIS A 42 PRO A 45 0 SHEET 2 B 2 LYS A 80 PHE A 83 -1 O ARG A 81 N PHE A 44 SHEET 1 C 3 ASP A 149 MET A 150 0 SHEET 2 C 3 ILE B 267 ARG B 272 -1 O LEU B 269 N MET A 150 SHEET 3 C 3 GLY B 275 LEU B 280 -1 O MET B 277 N HIS B 270 SHEET 1 D 3 GLY A 275 LEU A 280 0 SHEET 2 D 3 ILE A 267 ARG A 272 -1 N HIS A 270 O MET A 277 SHEET 3 D 3 ASP B 149 MET B 150 -1 O MET B 150 N LEU A 269 SHEET 1 E 9 ASN B 168 TYR B 173 0 SHEET 2 E 9 HIS B 139 THR B 144 1 N PHE B 142 O ILE B 172 SHEET 3 E 9 ARG B 198 GLU B 205 1 O VAL B 202 N VAL B 141 SHEET 4 E 9 GLY B 231 GLY B 238 -1 O ILE B 237 N VAL B 199 SHEET 5 E 9 THR B 31 ALA B 38 -1 N GLY B 36 O ALA B 234 SHEET 6 E 9 PHE B 250 VAL B 259 -1 O PHE B 250 N VAL B 32 SHEET 7 E 9 THR B 394 SER B 402 -1 O HIS B 401 N GLU B 251 SHEET 8 E 9 TRP B 383 GLY B 390 -1 N GLY B 384 O LEU B 400 SHEET 9 E 9 PHE B 315 PRO B 318 1 N ILE B 317 O VAL B 385 SHEET 1 F 2 HIS B 42 PRO B 45 0 SHEET 2 F 2 LYS B 80 PHE B 83 -1 O ARG B 81 N PHE B 44 LINK C GLY A 176 N CSD A 177 1555 1555 1.33 LINK C CSD A 177 N TYR A 178 1555 1555 1.33 LINK C GLY B 176 N CSD B 177 1555 1555 1.33 LINK C CSD B 177 N TYR B 178 1555 1555 1.33 CISPEP 1 MET A 150 PRO A 151 0 -0.08 CISPEP 2 MET A 150 PRO A 151 0 -0.14 CISPEP 3 GLY A 392 ILE A 393 0 -0.95 CISPEP 4 MET B 150 PRO B 151 0 -0.21 CISPEP 5 MET B 150 PRO B 151 0 -0.25 CISPEP 6 GLY B 392 ILE B 393 0 -0.72 CRYST1 74.320 89.050 70.670 90.00 95.50 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013455 0.000000 0.001296 0.00000 SCALE2 0.000000 0.011230 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014216 0.00000